+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prevnar"

Pneumococcal Vaccine Global Market Report 2024 - Product Thumbnail Image

Pneumococcal Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Conjugate Vaccine Global Market Report 2024 - Product Thumbnail Image

Conjugate Vaccine Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Global Vaccines Market Overview, 2023-28 - Product Thumbnail Image

Global Vaccines Market Overview, 2023-28

  • Report
  • September 2023
  • 114 Pages
  • Global
From
Global Vaccines Market Outlook, 2028 - Product Thumbnail Image

Global Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 194 Pages
  • Global
From
From
From
From
Pneumococcal Vaccines Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Pneumococcal Vaccines Market - Forecasts from 2022 to 2027

  • Report
  • May 2022
  • 110 Pages
  • Global
From
Disease Analysis: Pneumococcal Vaccines - Product Thumbnail Image

Disease Analysis: Pneumococcal Vaccines

  • Report
  • May 2021
  • 45 Pages
  • Global
Pneumococcal Vaccines Market and Forecast Analysis to 2022 - Product Thumbnail Image

Pneumococcal Vaccines Market and Forecast Analysis to 2022

  • Drug Pipelines
  • December 2018
  • 145 Pages
  • Global
From
V114 - Product Thumbnail Image

V114

  • Report
  • December 2018
  • 15 Pages
  • Global
From
Loading Indicator

Prevnar is a vaccine used to protect against pneumococcal disease, a type of bacterial infection that can cause serious illnesses such as pneumonia, meningitis, and sepsis. It is recommended for infants and young children, as well as adults over the age of 65. Prevnar is a conjugate vaccine, meaning it contains a combination of bacterial antigens that stimulate the body's immune system to produce antibodies. The vaccine is administered in a series of four doses, with the first dose given at two months of age. The Prevnar market is highly competitive, with several major players offering their own versions of the vaccine. These include Pfizer, Merck, GlaxoSmithKline, Sanofi Pasteur, and AstraZeneca. Each company has its own unique formulation of the vaccine, which is designed to provide the best protection against pneumococcal disease. Show Less Read more